Drugs / IFA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00089219 Background | Jul 2003 → May 2006 | cutaneous melanoma, ocular melanoma | University of Virginia | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IFA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00089219 ↗ |
| Modality | Other / unclassified | “vaccine adjuvant” NCT00089219 ↗ |